Literature DB >> 413937

The effect of intravesical thio-tepa on normal and tumor urothelium.

P T Nieh, J J Daly, J A Heaney, N M Heney, G R Prout.   

Abstract

Intravesical thio-tepa instillations for 55 patients with superficial transitional cell carcinoma were evaluated prospectively in the treatment of residual disease (therapeutic) and the prevention of recurrence (prophylactic). The over-all response rate to therapeutic thio-tepa was 56 per cent, with toxicity observed in 26 per cent of the cases. Patients with microscopic residual tumor showed better response and less toxicity than those with gross residual tumor. Prophylactic thio-tepa had no effect in lowering recurrence rates. Examination of pre-treatment and post-treatment biopsies showed no worsening of atypia and no correlation between improvement in atypia and gross tumor response. A charcteristic post-treatment thio-tepa effect was observed in non-tumorous urothelium but not in tumor biopsies. The differentiation of such thio-tepa effect cells from pre-malignant atypical cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 413937     DOI: 10.1016/s0022-5347(17)57383-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Superficial bladder cancer: state of the art.

Authors:  A V Bono
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 2.  Intravesical chemotherapy in the United States. An overview.

Authors:  J T Spaulding
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.

Authors:  T Niijima; K Koiso; H Akaza
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.

Authors:  M Pavone-Macaluso; M Tripi; G B Ingargiola
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  In vitro chemosensitivity of J-82 human bladder cancer cells.

Authors:  K C Anderson; W G Simpson; R J Ballou; J I Harty; M T Tseng
Journal:  Urol Res       Date:  1986
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.